A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome: a California Cancer Consortium Study.

ABSTRACT:

SUBMITTER: Kirschbaum MH 

PROVIDER: S-EPMC5360527 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature